BW
BSX icon

Boaz Weinstein’s Boston Scientific BSX Stock Holding History

Boaz Weinstein’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-410,000
Closed -$20.5M – 637
2023
Q1 		$20.5M Sell
410,000
-500,000
-55% -$23.6M 0.39% 53
2022
Q4 		$42.1M Hold
910,000
– – 0.57% 18
2022
Q3 		$35.2M Buy
910,000
+410,000
+82% +$16.4M 0.4% 20
2022
Q2 		$18.6M Buy
+500,000
New +$20.4M 0.22% 105

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Boaz Weinstein's BSX Position: Q2 2023 in Review

Boaz Weinstein sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 4,730 shares — an estimated $237K sold.

Boaz Weinstein first reported a position in BSX in Q2 2022 and held it in 4 quarters. The position peaked at $15.6M in Q3 2022. 1,067 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • Boaz Weinstein reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
  • Boaz Weinstein sold 4,730 Boston Scientific shares in Q2 2023, an estimated $237K.
  • Boaz Weinstein first reported a position in Boston Scientific in Q2 2022 and held it in 4 quarters.
  • Boaz Weinstein's Boston Scientific position peaked at $15.6M in Q3 2022.
  • 1,067 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Saba Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.